The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non-muscle-invasive bladder cancer
详细信息 查看全文
- 作者：J. Alfred Witjes ; M.D. ; Ph.D.a ; fred.witjes@radboudumc.nl" class="auth_mail" title="E-mail the corresponding author ; francescapisano85@gmail.com" class="auth_mail" title="E-mail the corresponding author ; Guido Dalbagni ; M.D.b ; Robert J. Karnes ; M.D.c ; Shahrokh Shariat ; M.D.d ; Steven Joniau ; M.D. ; Ph.D.e ; Joan Palou ; M.D. ; Ph.D.f ; Vincenzo Serretta ; Ph.D.g ; Sté ; phane Larré ; M.D.h ; Savino di Stasi ; M.D. ; Ph.D.i ; Renzo Colombo ; M.D. ; Ph.D.J ; Marek Babjuk ; M.D. ; C.Sc.k ; Per-Uno Malmströ ; m ; M.D.l ; Nuria Malats ; M.D.m ; Jacques Irani ; Ph.D.n ; Jack Baniel ; Ph.D.o ; Tommaso Cai ; M.D.p ; Eugene Cha ; M.D.q ; b ; Peter Ardelt ; M.D.r ; John Varkarakis ; Ph.D.s ; Riccardo Bartoletti ; M.D.t ; Martin Spahn ; M.D. ; Ph.D.u ; Francesca Pisano ; M.D.v ; Paolo Gontero ; M.D.v ; Richard Sylvester ; M.D.w
- 刊名：Urologic Oncology: Seminars and Original Investigations
- 出版年：2016
- 出版时间：November 2016
- 年：2016
- 卷：34
- 期：11
- 页码：484.e19-484.e25
- 全文大小：474 K
文摘
- •
Without maintenance, Connaught is more effective than TICE for the time to first recurrence.
- •
This superiority is potentially because of a stronger initial immune response caused by Connaught BCG.
- •
When maintenance was given, TICE is more effective than Connaught for the time to first recurrence.